Login to Your Account

U.S. patent disclosures

Friday, February 21, 2014
Avaxia Biologics Inc., of Lexington, Mass., was issued U.S. Patent No. 8,647,626, “Compositions Comprising TNF-specific Antibodies for Oral Delivery.” The patent covers AVX-470, Avaxia’s treatment for inflammatory bowel disease.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription